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oxalate even though they grew significantly in oxalate-containingReduction of oxaluria after an oral course of lactic acid bacteria
medium. No strain expressed the Ox1T gene.at high concentration.
Conclusions. The urinary excretion of oxalate, a major riskBackground. Hyperoxaluria is a major risk factor for renal
factor for renal stone formation and growth in patients withstones, and in most cases, it appears to be sustained by increased
idiopathic calcium-oxalate urolithiasis, can be greatly reduceddietary load or increased intestinal absorption. Previous studies
with treatment using a high concentration of freeze-dried lactichave shown that components of the endogenous digestive mi-
acid bacteria. We postulate that the biological manipulationcroflora, in particular Oxalobacter formigenes, utilize oxalate
of the endogenous digestive microflora can be a novel approachin the gut, thus limiting its absorption. We tested the hypothesis
for the prevention of urinary stone formation.of whether oxaluria can be reduced by means of reducing
intestinal absorption through feeding a mixture of freeze-dried
lactic acid bacteria.
Methods. Six patients with idiopathic calcium-oxalate uro- Hyperoxaluria is a risk factor for renal stones, and the
lithiasis and mild hyperoxaluria (40 mg/24 h) received daily urine load of oxalate plays a pivotal role in calcium-a mixture containing 8  1011 freeze-dried lactic acid bacteria
oxalate stone formation even in normocalciuric patients(L. acidophilus, L. plantarum, L. brevis, S. thermophilus, B.
[1]. In normal individuals, the majority of urinary oxalateinfantis) for four weeks. The 24-hour urinary excretion of oxa-
late was determined at the end of the study period and then is derived from the endogenous metabolism of glycine,
one month after ending the treatment. The ability of bacteria glyoxylate, and ascorbic acid, and 10 to 20% is derived
to degrade oxalate and grow in oxalate-containing media, and from oral ingestion [2]. The colon is the major site of
the gene expression of Ox1T, an enzyme that catalyzes the oxalate absorption, with 3 to 5% of dietary oxalate beingtransmembrane exchange of oxalate, also were investigated.
absorbed under normal conditions [2]. However, an in-Results. The treatment resulted in a great reduction of the
creased intestinal absorption of oxalate may lead to24-hour excretion of oxalate in all six patients enrolled. Mean
levels  SD were 33.5  15.9 mg/24 h at the end of the study hyperoxaluria with a significantly enhanced risk of uri-
period and 28.3 14.6 mg/24 h one month after treatment was nary stone formation [3–5]. A study performed on a
interrupted compared with baseline values of 55.5 19.6 mg/24 h population of idiopathic calcium oxalate stone formers
(P 0.05). The treatment was associated with a strong reduction
with mild hyperoxaluria found no evidence of any appre-of the fecal excretion of oxalate in the two patients tested.
ciable alteration in the renal oxalate transport, and con-Two bacterial strains among those used for the treatment (L.
cluded that an increased dietary load of oxalate with aacidophilus and S. thermophilus) proved in vitro to degrade
oxalate effectively, but their growth was somewhat inhibited by possible hyperabsorption was the responsible mecha-
oxalate. One strain (B. infantis) showed a quite good degrading nism [6]. The relative amounts of calcium and oxalate
activity and grew rapidly in the oxalate-containing medium. L. in the diet may be an important variable in determiningplantarum and L. brevis showed a modest ability to degrade
the rate of oxalate absorption and urinary excretion [7],
although there is evidence that increased absorption with
the consequent hyperoxaluria may be caused by a varietyKey words: stone formation, idiopathic calcium-oxalate urolithiasis,
digestive microflora, hyperoxaluria. of intestinal disorders, including the syndrome of bacte-
rial overgrowth and ileal resections for inflammatoryReceived for publication July 7, 2000
bowel disease [3–5]. In fact, since 1968, nephrolithiasisand in revised form March 14, 2001
Accepted for publication March 16, 2001 has been recognized as a complication of inflammatory
bowel disease or intestinal resection [8]. 2001 by the International Society of Nephrology
1097
Campieri et al: Lactic acid bacteria and oxaluria1098
Several studies have demonstrated the presence of Therefore, we explored the possibility of reducing the
urinary excretion of oxalate by means of reducing theoxalate-degrading bacteria in the human intestine [9–13],
raising the view that the maintenance of a normal ecol- intestinal absorption through the use of a mixture of
freeze-dried lactic acid bacteria.ogy among the bacterial species that constitute the en-
dogenous digestive microflora is a natural defense mech-
anism against urolithiasis. Based on these overall data,
METHODS
it is clear that the metabolism of oxalate by intestinal
Patientsbacteria should be a focus of investigation in subjects
with a recurrent production of urinary stones. Six patients with idiopathic calcium-oxalate urinary
stone disease (at least one chemically demonstrated cal-The possibility of a biological manipulation of oxalate
in the gut has been known since 1955 from a report of cium-oxalate stone passed during the previous year) and
mild hyperoxaluria (40 mg/24 h) were selected for thisoxalate destruction by the rumen contents of the cows
[14] and later by a mixed bacterial flora from the large study. All of them had 24-hour urinary excretion of cal-
cium, phosphate, and citrate within the normal rangeintestine of other herbivores [15]. In 1985, Allison et al
reported the specific oxalate-degrading effect of Oxalo- and normal blood levels of parathyroid hormone (PTH).
PTH was measured using a commercially available im-bacter formigenes, an inhabitant of the large bowel of
humans and other animals [10]. This anaerobic bacte- munometric chemiluminescent assay (Immulite 2000;
DPC Diagnostic Products Corporation, Los Angeles,rium takes metabolic energy from the decarboxylation of
oxalate by using the so-called proton-motive metabolic CA, USA). The dietary intake of calcium ranged from
0.8 to 1.2 g daily. None had gastrointestinal diseasescycle [16]. This is accomplished by the combined action
of at least three different proteins. The first is repre- potentially responsible for the hyperoxaluria, and there
was no history of treatment with antibiotics in the previ-sented by the oxalate/formate antiporter, encoded by
the OxlT gene [17], which catalyzes the exchange of ous six months. The patients presented two main renal
risk factors: either frequent stone emission or the pres-extracellular oxalate, a divalent anion, and intracellular
formate, a monovalent anion derived from the oxalate ence of a reduced renal mass (2 patients). The serum
creatinine concentration was within the normal limits indecarboxylation. Indeed, once inside the bacterium, the
oxalate is activated by the formyl coenzyme A trans- all patients. All of the patients had stable hyperoxaluria
over the three months preceding their enrollment intoferase, encoded by the frc gene [18], which transfers a
coenzyme A moiety to the oxalic acid. The oxalyl- the study.
coenzyme A is then subject to the reaction catalized by
Freeze-dried lactic acid bacteriathe oxalyl-coenzyme A decarboxylase, encoded by the
oxc gene [19], which leads to the formation of formate Lactobacillus acidophilus, Lactobacillus plantarum,
Streptococcus thermophilus, Bifidobacterium infantis, andand carbon dioxide. The electogenic action of the oxa-
late/formate antiporter develops an internally negative Lactobacillus brevis (CD2) were purchased from the
YOMO Research Centre [Zelo B. Persico (LO), Italy].membrane potential, and since the decarboxylation reac-
tion consumes an internal proton, the combined activity All strains were stored freeze dried in a refrigerated
room. B. infantis was cultured in MRS broth (DIFCO,of the antiporter and of the decarboxylase would pro-
duce an indirect proton pump. In this way, O. formigenes Detroit, MI, USA) 0.5% glucose and incubated anaer-
obically at 37C for 18 hours in Gas Pack with CO2 andestablished the proton-motive force required for both
the synthesis of adenosine 5-triphosphate (ATP) and H2 atmosphere. L. acidophilus and L. plantarum were
cultured in MRS broth (DIFCO) and incubated at 37Cother membrane reactions requiring a proton-motive
force. Lately, the absence of O. formigenes has been for 18 hours. L. brevis was cultured in MRS broth
(DIFCO) and incubated at 30C for 18 hours. S. ther-proposed as a risk factor for hyperoxaluria in cystic fi-
brosis patients [20]. However, not all individuals who mophilus was cultured in M17 broth (DIFCO)  0.5%
lactose and incubated at 37C for 18 hours.tested negative for O. formigenes in this study were hyp-
eroxaluric, indicating that other components of the gut
Testing lactic acid bacteria for growth in oxalate andflora also could be important in terms of substrate utiliza-
oxalate-degrading capacitytion.
Lactic acid bacteria are a group of bacteria belonging Culture media containing both 10 and 20 mmol/L am-
monium oxalate (BDH) was prepared by adding 10 mLto diverse genera used in the dairy industry and are
composed mainly of bacteria, of which the primary meta- of the 0.46 filter sterilized sugar and ammonium oxalate
solutions listed below to 10 mL base media [proteosebolic end-product of carbohydrate metabolism is lactic
acid. The use of lactic acid bacteria to reduce the accumu- peptone no. 3 (DIFCO) 10 g  yeast extract (DIFCO)
5 g  Tween ‘80 (DIFCO) 1 mL  KH2PO4 (BDHlation of uremic toxins by modifying the intestinal flora
has already been employed in humans [21, 22]. Chemicals, Poole, UK) 2 g  Na acetate (BDH) 5 g 
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di-Ammoniumhydrogen-citrate (MERK; Darmstadt, Ger- degradation, as indicated in Table 1, were calculated
with reference to the “medium blank” in order to elimi-many) 2 g  MgSO4.7H2O (Merck, Rahway, NJ, USA)
0.05 g  MnSO4 (Merck) 0.05 g  water q.s. to 500 mL nate the interference of the cultures or the treatment
methods.and sterilized at 121C for 15 min].
The sugar and ammonium oxalate solutions were pre-
Expression of Ox1T genepared according to the bacterium to be cultured, as fol-
lows: The presence of Ox1T, frc, and oxc genes in lactic
acid bacteria was studied by means of polymerase chain(1) For L. acidophilus, L. plantarum, L. brevis. A,
ammonium oxalate 20 mmol/L glucose (BDH) 40 g/L; reaction (PCR) amplification of genomic DNA using
specific primers. Genomic DNA form O. formigenesB, ammonium oxalate 40 mmol/L  glucose 40 g/L.
(2) For S. thermophilus. A, ammonium oxalate 20 (kindly donated by M.G. Allison) was used as a positive
control. Briefly, DNA was extracted using the QIAampmmol/L  glucose 40 g/L  lactose (DIFCO) 10 g/L; B,
ammonium oxalate 40 mmol/L  glucose 40 g/L  lac- DNA Mini Kit (Qiagen, Chatsworth, CA, USA). The
integrity of DNA was controlled on an 0.8% agarose geltose 10 g/L
(3) For B. infantis. A, ammonium oxalate 20 mmol/L electrophoresis. PCR amplification of the Ox1T, frc, and
oxc genes was performed using the following primers:glucose 50 g/L; B, ammonium oxalate 40 mmol/L  glu-
cose 50 g/L. Ox1T (amplified product 191 bp), upstream AACAGG
CCTCTTGGGCAATC, downstream CACCAGGCTGAfter mixing, each sample marked A contained 10
mmol/L, while each sample marked B contained 20 AGAACCAGCTTT; frc (amplified product 273 bp), up-
stream GTCATTCTGGCTTCCGTTAA, downstreammmol/L of ammonium oxalate. Culture broths were then
inoculated at 10% with a fresh culture and incubated TACGAACCAGATTCAGAACA; and oxc (amplified
product 385 bp), upstream CCTGAAAATGAATGACunder suitable conditions for each strain (inoculum per-
centage, incubation time, and temperature of the inocu- ATGC, downstream CGATTGGAATGTCTTTGATG.
For each amplification, 1 g of genomic DNA in alated samples). For each sample, a “medium blank,” that
is, a culture medium prepared as described previously final volume of 50 L containing MgCl2 1.5 mmol/L, 20
pmol of each primer, 10 mmol each of the four deoxy-in this article but with no inoculum of bacteria, was also
prepared and treated in the same manner. The number nucleotides, 0.5 units Taq-polymerase (Amplitaq; Perkin
Elmer) were used. PCR reaction was yielded in a 9600of microorganisms in each broth was counted after incu-
bation under the conditions and for the times noted: L. PE thermocycler (Perkin Elmer), and consisted of 35
cycles at 94C for one minute, 62C for one minute, 72Cacidophilus in MRS agar, incubated anaerobically at
37C for three days; L. plantarum in MRS agar, incubated for one minute, and a final ten-minute extension step at
72C. For each sample, 18 L of the PCR amplificationat 37C for three days; S. thermophilus in M17 agar,
incubated at 37C for two days; L. brevis in MRS agar, product were analyzed on 2% agarose gel and stained
with ethidium bromide. To monitor the specificity of theincubated at 37C for three days; and B. infantis in HHD
agar, incubated anaerobically at 37C for three days. reverse transcription (RT)-PCR products, the amplified
DNAs were recovered from the agarose gel and were
Methods for oxalate detection purified and underwent sequencing reaction in the pres-
ence of fluorescent labeled nucleotides and analyzed byBroth cultures were pasteurized at 90C for 15 minutes
and then centrifuged at 5000 rpm for 10 minutes, and ABI PrismDNA sequencer (Perkin Elmer). All of the
obtained sequences corresponded to the expected onesfinally, the supernatant was filtered with a 0.45 micron
filter. Oxalic acid in the cultural media was determined (data not shown).
with the “Oxalic acid” Kit (Boehringer Mannheim,
Design of the studyMonza, Italy). The analysis was performed by spectro-
photometer (Perkin Elmer Lamba 5; GMBH, Uber- Each patient received 4 g/day of freeze-dried lactic
acid bacteria for four weeks. Each gram of this mixturelingen, Germany) at 340 nm; this assay is specific for
oxalic acid with a detection limit of 1.6 mg/L. The small- contained 2 1011 bacteria (L. acidophilus, L. plantarum,
L. brevis, S. thermophilus, B. infantis). The differentest differentiating absorbance for the procedure is 0.005
absorbance units, which corresponds to a maximum sam- strains were mixed in a 1:1:1:1:1 ratio and prepared in
granular form. The preparation was administered twiceple volume 0.500 mL and measurement at 340 nm of an
oxalic acid concentration of 0.4 mg/L sample solution. per day before meals after suspension in cold water, and
all patients defined the preparation as good in terms ofIn a double determination using one sample solution, a
difference of 0.005 to 0.010 absorbance units may occur. palatability. No change in the previous diet was allowed,
and the daily fluid intake was encouraged to maintainWith a sample volume of 0.100 mL and measurement at
340 nm, this corresponds to an oxalic acid concentration at least 1.5 L of urinary output. Foods rich in oxalate,
such as spinach, rhubarb, chocolate, peanuts, and cocoa,of approximately 2 to 4 mg/L. The results of oxalate
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Table 1. In vitro growth and degradation of ammonium oxalate by different strains of lactic acid bacteria
Ammonium oxalate 10 mmol/L Ammonium oxalate - 20 mM
Microbial content CFU/mL  10 6 Microbial content CFU/mL  10 6
Degradation Degradation
Lactic acid bacteria % Time 0 End growth % Time 0 End growth
L. plantarum 1.42 32 270 0.00 32 230
L. brevis 0.94 27 130 0.73 27 120
S. thermophilus 2.31 2.5 28 3.06 2,5 9
L. acidophilus 11.79 25 130 3.41 25 52
B. infantis 5.26 36 300 2.18 36 230
One experiment representative of three performed is reported.
were not allowed. The patients had two determinations added. Extrapolating to a sample of unknown oxalate
of 24-hour oxaluria at intervals ranging from three to concentration, we detected from 62 to 68% of the real
eight weeks before treatment and 30 and 60 days from amount. This induced a proportional error of 6%. The
the beginning of the treatment. In two patients, the fecal total error was estimated to be from 10 to 20% of the
oxalate content was determined before and after treat- reported value, with respect to higher or lower oxalic
ment. concentrations. The fixed error has been reported for
the UV method and confirmed by our own standard
Urine and fecal oxalate content
curve.
Oxaluria was determined on a 24-hour collection of
urine to which 10 mL/L of 37% hydrochloric acid had Statistical analysis
been added. Enzymatic determination was performed
The statistical analysis of results was performed usingaccording to the clinical diagnostic kit from Sigma (Oxa-
analysis of variance (ANOVA).late; Sigma diagnostic no. 591). The analysis was per-
formed by spectrophotometer (Perkin Elmer) at 590 nm.
In the feces, the oxalic acid concentration was detected RESULTS
according to the “Oxalic acid UV-method (Boehringer
In vitro growth of bacterial strainsMannheim).” Since fecal samples contain many sub-
and oxalate degradationstances that can interfere with the ultraviolet (UV)
method, they were purified. Briefly, 1 g of feces was All of the selected strains were grown in the presence
diluted in 19 mL of phosphate buffer (0.1 mol/L, pH 7.0) of ammonium oxalate 10 mmol/L, while at a concentra-
and treated with the following reagents as mentioned in tion of 20 mmol/L, the growth of L. acidophilus and
the UV method: EDTA, to neutralize ions that form S. thermophilus was partially inhibited. There was no
oxalic salts of low solubility (that is, Ca2); trichloroacetic relationship between bacterial growth and oxalate degra-
acid, to precipitate proteins; (following separation of dation. L. plantarum and L. brevis, in fact, degraded
solid materials by centrifugation) H2O2, to remove reduc- little or no oxalate despite showing significant growth.
ing substances; and activated charcoal, to remove pheno- In contrast, L. acidophilus and S. thermophilus degraded
lic substances (followed by separation of solid materials oxalate at both concentrations in spite of the reduced
by filtration). Once purified, the oxalic acid UV method growth in the presence of 20 mmol/L ammonium oxalate.
was employed upon the fecal sample. The results ob-
Finally, B. infantis showed quite good degrading activity
tained by this method represent 62 to 68% of the real
and was not inhibited by the ammonium oxalate at eitheroxalic acid concentration present in the sample. Organic
concentration. One representative experiment is shownoxalate may bind to some extent to activated charcoal,
in Table 1.as witnessed by the loss of an almost stable amount of
To verify the capacity of our lactic acid bacteria to32 to 38%. It is also possible that a proportion of oxalate
grow and degrade ammonium oxalate further, experi-was lost due to absorption to cell bulk. The fixed error
ments were performed with and without the addition ofhas been reported by the UV method and was confirmed
sugars (glucose and lactose). Since in absence of sugarsby our own standard curve. The proportional error was
the strains did not show any growth, it can be confirmeddetermined in our laboratory from samples of different
that the sugars are the main fuel for the bacterial growthpatients with different diseases and with the addition of
(data not shown). The lactic acid bacteria employed indifferent quantities of a known oxalate stock solution.
this study therefore should be considered as “generalist”In these samples, the increment in oxalate concentration
detected was always between 62 to 68% of the amount in terms of oxalate degradation.
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Expression of O. formigenes genes
In view of the ability of some of the lactic acid bacteria
to degrade oxalate, PCR was used to investigate the
possible presence of the OxlT, frc, and oxc genes in the
genomic DNA extracted from all the bacteria strains
used in this study as well as from the O. formigenes as
the positive control. To this purpose, two different sets
of primers were used as specified in the Methods section.
The results (Fig. 1) show the presence of the expected
amplification products from O. formigenes genomic DNA,
while no amplification products for the three genes were
observed from the S. thermophilus, L. acidophilus, B.
infantis, L. plantarum, and L. brevis genomic DNA.
Effect of in vivo treatment on oxaluria
According to the previously mentioned experiments,
even though some strains showed more effective results
than others for the purpose of our study, we decided to
utilize all of them in the form of a granulate containing
not less than 2  1011 CFU per gram of freeze-dried
microorganisms. The mixture of the lactic acid bacteria
was very well tolerated. None of the patients experienced
abdominal discomfort or alterations in their usual bowel
movements. Blood chemical and hematological values
disclosed no change between pretreatment and after-
treatment checks.
The 24-hour urinary excretion of oxalate was greatly
reduced at the end of the study period in all six patients
enrolled. This effect of the treatment was sustained over
time, since oxaluria was significantly reduced compared
with the baseline levels even at measurements performed
one month after the treatment with lactic acid bacteria
was interrupted (Table 2).
Furthermore, the two patients (number 4 and number
6) who were tested for the fecal excretion of oxalic acid
showed a large reduction of fecal content of oxalate after
30 days of treatment—by 23 and 40%, respectively—
compared with baseline values (Table 3).
The daily urinary excretion of calcium and the amount
of urine output were normal before treatment was
started and did not change throughout the study period
(Table 4). Other metabolic parameters, such as phospha- Fig. 1. Polymerase chain reaction (PCR) amplification of the OxlT, frc,
and oxc genes from different lactic acid bacteria, as well as from theturia, citraturia, and blood levels of PTH, were not modi-
Oxalobacter formigenes. Genomic DNA extracted from different lacticfied by the treatment (Tables 5 and 6). acid bacteria and from Oxalobacter formigenes used as positive control
was analyzed by PCR to investigate the presence of the OxlT (A), frc
(B), and oxc (C) genes. One microgram of DNA was amplified using
DISCUSSION specific primers, as described in the Methods section. PCR products
were then run on 2% agarose gel and stained with ethidium bromide.Renal stone disease accounts for approximately 7 to Data presented are representative of three independent experiments.
10 out of every 1000 hospital admissions in the United
States and Europe, and has an annual incidence of 7 to 21
cases per 10,000 persons [23]. For patients with idiopathic
zymes that can degrade oxalate present in the diet (thatcalcium oxalate stone disease, treatment is directed to-
is, oxalate oxidase) is rendered difficult in so far as theseward recommending certain dietary restrictions and drug
enzymes are likely to be inactivated in the digestive tractadministration (thiazide diuretics, potassium citrate, cel-
lulose phosphate, pyridoxine). Administration of en- by proteolytic enzymes following ingestion [24].
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Table 2. Hyperoxaluric patients with stone disease before and at different time intervals after treatment
Oxaluria mg/24 h
Patient Sex, age Beforea At day 30 At day 60 Stone History
1 M, 48 50 7 8 Elimination of 3 CaOx stones over the last 2 years
2 M, 47 47 30 22 Elimination of 2 CaOx stone over the last year
3 F, 47 41 31 25 Elimination of 1 CaOx stone over the last year in a solitary kidney
4 M, 16 95 56 52 Elimination of 1 CaOx stone every 2 years over the last 8 years
5 F, 33 51 38 28 Elimination of 2 CaOx stones every year over the last 2 years
6 F, 42 49 39 35 Elimination of 1 CaOx stone every year in a 15-year solitary kidney
Mean 55.5 33.5a 28.3b
SD 19.6 15.9 14.6
a Levels of oxaluria reported in the table are the last determination at 3 weeks before enrollment; for patient 1 oxaluria was 53 mg/24h at 	6 weeks; for patient
2 oxaluria was 45 mg/24h at 	8 weeks; for patient 3 oxaluria was 40 mg/24h at 	7 weeks; for patient 4 oxaluria was 90 mg/24h at 	6 weeks; for patient 5 oxaluria
was 45 mg/24h at 	7 weeks; for patient 6 oxaluria was 50 mg/24h at 	6 weeks
bP 0.016 compared to pretreatment levels
cP 0.021 compared to levels at day 30 and P  0.0001 for the trend throughout the study period
Table 3. Concentration of oxalic acid in the feces of two patients oxaluria rather than supersaturation has been suggested
before and after a four week treatment
to be the most important variable for stone formation
Before After Change [26]. An additional point is that we do not exactly know
Patient treatment treatment % what change in urine supersaturation is associated with
No. 4 74395 44377 	40.323 a decrease in stone formation. Assuming that all other
No. 6 1,400135 1,072115 	23.315
variables are unchanged, even a small change in the
Results expressed in mg oxalic acid/g wet feces; (proportional error 6%, fixed
absolute urinary excretion of oxalate could lead to sub-error 50 g/g wet feces).
stantial changes in supersaturation. Remarkably, several
metabolic parameters, such as the blood levels of PTH
and the urinary excretion of calcium, phosphorus, and
Since oxalate-degrading bacteria are present in the citrate, were not affected by the study treatment with
endogenous microflora of human intestine, we hypothe- lactic acid bacteria.
sized that the colonization of the gut of subjects with To date, the only real candidate for such a procedure
hyperoxaluria using oxalate-degrading bacteria could be has been O. formigenes [27]. Most children are colonized
an alternative and original approach to reduce the intes- by O. formigenes at an early age. Even though a number
tinal absorption of oxalate and the resulting urinary ex- of adults show this colonization, it has been hypothesized
cretion. Furthermore, while an oxalate-degrading strain that repeated or long-lasting antibiotic treatment can
of Enterococcus faecalis has been recently isolated from
lead to its disappearance from the gut [20]. O. formigenes
human stools under anaerobic conditions [13], it is a
apparently regulates the absorption of oxalic acid throughpotentially pathogenic organism that cannot be safely
the gut when present at a concentration ranging fromused for oral bacteriotherapy.
106 to 108 CFU per gram of feces [27]. The observationOur study shows that feeding a mixture of freeze-dried
that not all patients who tested negative for O. formi-lactic acid bacteria led to a significant reduction of the
genes in the study by Sidhu et al were also hyperoxaluricurinary excretion of oxalate in a group of patients with
[18] led us to hypothesize that several other bacteria,idiopathic calcium-oxalate urolithiasis and mild hyper-
even if they were “generalist” in term of substrate utiliza-oxaluria. The sample of patients we investigated was
tion, might degrade oxalate [20]. Our choices were di-small, as only six patients were enrolled in this prelimi-
rected toward bacteria with the following characteristics:nary feasibility study. However, an important point that
(1) not pathogenic for humans, (2) easily obtainable, andsupports the relevance our results is that no discrepancy
(3) able to colonize the gut. It was logical to focus onwas observed among those subjects regarding the impact
lactic acid bacteria as a potential therapeutic strategy.of the experimental therapy on oxaluria. The urinary
Our study employed a number of lactic acid bacteriaexcretion of oxalate indeed was significantly reduced by
that were negative when assayed for the presence oftreatment with lactic acid bacteria in each of the six
the oxalate:formate antiporter (Ox1T). Ox1T is a singlepatients in our study group.
membrane protein that mediates the exchange of for-The treatment was associated with a mean reduction
mate and oxalate without an additional input of energyin oxaluria of 30 mg/day, but even this change may be
[16–19]. These bacteria are commonly found in manybiologically important. In fact, only a relatively small
dairy products at low concentration (that is, 104 to 108difference in urine supersaturation appears to exist be-
tween stone formers and non-stone formers [25], and CFU per gram) [27]. This pilot trial employed a granulate
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Table 4. Daily urinary excretion of calcium and amount of urine output at baseline and throughout the study period
Urinary calcium mg/24 h Diuresis mL/24 h
Patient
number Pre-treatment 30 days 60 days Pre-treatment 30 days 60 days
1 245 210 225 1150 1300 1450
2 180 201 196 1360 1500 1550
3 270 250 275 1600 1750 1800
4 200 210 215 1470 1500 1680
5 285 290 275 1700 1890 1950
6 230 240 225 1400 1400 1380
Values are the mean of triplicate measurements performed each day on three consecutive days.
Table 5. Blood levels of parathyroid hormone and daily urinary excretion of phosphorus at baseline and throughout the study period
Blood parathyroid hormone pg/mL Urinary phosphorus g/24 h
Patient
number Pre-treatment 30 days 60 days Pre-treatment 30 days 60 days
1 42 40 43 0.9 ND 0.9
2 30 34 31 0.8 0.7 0.8
3 51 not done 50 1.3 1.4 1.3
4 50 46 49 1.2 1.3 not done
5 58 53 60 0.9 0.9 not done
6 61 not done 63 1.3 1.1 1.4
Table 6. Daily urinary excretion of citrate at baseline and acid bacteria at concentration superior to 1011 get colo-
throughout the study period
nized at week 3 after the start of the treatment [28].
Urinary citrate mg/24 h This latter study has demonstrated that feeding a similar,Patient
number Pre-treatment 30 days 60 days although somewhat different, mixture of bacteria led to
a measurable colonization of the intestinal ecological1 450 430 440
2 390 400 400 niches, though colonization was transient as fecal counts
3 560 not done 545 of lactic acid bacteria returned to the pretreatment level
4 620 640 630
15 days after the feeding was stopped. Our investigation5 580 600 not done
6 495 510 500 did not measure the fecal counts of bacteria directly, but
it is reasonable to suppose that intestinal colonization
could occur with a similar kinetics. The fact that we
found reduced fecal oxalate excretion in two patients
made by a mixture of lactic acid bacteria at a concentra- indirectly confirms that oxalate-degrading bacteria effec-
tion of 1011 (total daily dosage was 800  1011 CFU). tively colonized the intestine. However, it is probable
This high concentration is able to induce colonization of that the use of this mixture of lactic acid bacteria resulted
the gut by lactic acid bacteria, as previously reported in a more stable colonization of the gut, as the reduction
[28]. Notably, the manipulation of the gut ecosystem by in urinary and fecal excretion of oxalate was still signifi-
administering O. formigenes suffers from the fact that cant at measurements performed one month after stop-
O. formigenes is a strict anaerobe and could have diffi- ping the treatment. Microbiological studies are in prog-
culty in colonizing certain regions of the gut (such as the ress to confirm this hypothesis. Our preparation mixed
small intestine) where an appreciable amount of oxygen bacteria that are “good” oxalate degraders but character-
is present [27]. An additional difficulty could be related ized by a reduced growth (S. thermophilus, L. acidophilus),
to the “absolute” need of oxalate by O. formigenes for with bacteria that grow well in the presence of oxalate
its growth; we can envisage that hyperoxaluric patients but are less good as oxalate degraders (L. plantarum, L.
could require some oxalate to be administered together brevis); only one strain (B. infantis ) has both properties,
with O. formigenes in order to get an appreciable coloni- to some extent. In fact, if we look at the absolute degra-
zation. In the case of the lactic acid bacteria, the presence dation in vitro, L. plantarum and L. brevis degrade oxa-
of oxalate is not a limitation, and even though they are late only to a limited extent. However, we theorized that
apparently “generalists” in terms of oxalate degradation, it was important to add these bacteria to the preparation
the high number administered to the patients resulted since they are “good” colonizers of the host’s gut [28],
in an appreciable reduction of the oxaluria. In addition, and in this site, they could play a major role for the
reduction of oxaluria observed in vivo. This hypothesisas previously demonstrated, patients treated with lactic
Campieri et al: Lactic acid bacteria and oxaluria1104
is confirmed by the observation that the urinary excre- NOTE ADDED IN PROOF
tion of oxalate is still present, or even further increased, The product used in this study (Oxadrop) is now
after one month following the interruption of the treat- available from VSL Pharmaceuticals, Gaithersburg, MD,
ment by our patients. It remains to be clarified why the USA.
percentage of oxalate found in feces both in controls
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